38.88
price down icon3.88%   -1.57
after-market Dopo l'orario di chiusura: 38.88
loading
Precedente Chiudi:
$40.45
Aprire:
$40.07
Volume 24 ore:
144.27K
Relative Volume:
1.28
Capitalizzazione di mercato:
$582.31M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-15.61%
1M Prestazione:
+3.96%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$37.50
$40.30
Intervallo di 1 settimana:
Value
$37.50
$48.63
Portata 52W:
Value
$15.00
$48.63

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name
Nome
Tectonic Therapeutic Inc
Name
Telefono
(339) 666-3320
Name
Indirizzo
490 ARSENAL WAY, WATERTOWN
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
TECX's Discussions on Twitter

Confronta TECX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
TECX 38.88 582.31M 0 0 0 0.00
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Tectonic Therapeutic Inc Borsa (TECX) Ultime notizie

pulisher
Nov 14, 2024

Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $69.00 - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High Following Analyst Upgrade - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks - TipRanks

Nov 14, 2024
pulisher
Nov 13, 2024

Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High on Analyst Upgrade - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst Upgrade - Defense World

Nov 13, 2024
pulisher
Nov 12, 2024

Tectonic Therapeutic Inc. Reports Q3 2024 Results - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

BML Capital Management LLC Sells 254,295 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Tectonic Therapeutic (NASDAQ:TECX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain - Simply Wall St

Nov 12, 2024
pulisher
Nov 12, 2024

Tectonic Therapeutic price target raised to $79 from $55 at Wells Fargo - TipRanks

Nov 12, 2024
pulisher
Nov 11, 2024

Tectonic Therapeutic Announces Positive Phase 1a Results in - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Tectonic's TX45 Shows Strong Phase 1 Results: 42% Renal Flow Boost, 20-Day Half-Life | TECX Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 09, 2024

Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.38 - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $68.50 - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives $23.83 Average PT from Analysts - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World

Nov 09, 2024
pulisher
Nov 07, 2024

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Tectonic Therapeutic (NASDAQ:TECX) Reaches New 12-Month HighStill a Buy? - MarketBeat

Nov 07, 2024
pulisher
Nov 05, 2024

Mineralys Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance

Nov 05, 2024
pulisher
Nov 03, 2024

Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High – Still a Buy? - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Reviewing Tectonic Therapeutic (NASDAQ:TECX) and Mesoblast (NASDAQ:MESO) - Defense World

Nov 03, 2024
pulisher
Nov 01, 2024

Tectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year HighTime to Buy? - MarketBeat

Nov 01, 2024
pulisher
Oct 28, 2024

X4 Pharmaceuticals (NASDAQ:XFOR) vs. Tectonic Therapeutic (NASDAQ:TECX) Critical Analysis - Defense World

Oct 28, 2024
pulisher
Oct 27, 2024

Tectonic Therapeutic Independent Director Acquires 7.0% More Stock - Yahoo Finance

Oct 27, 2024
pulisher
Oct 26, 2024

Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High on Insider Buying Activity - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High Following Insider Buying Activity - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Tectonic Therapeutic (NASDAQ:TECX) Director Acquires $10,077,000.00 in Stock - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock By Investing.com - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock - Investing.com India

Oct 24, 2024
pulisher
Oct 22, 2024

BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - The Manila Times

Oct 22, 2024
pulisher
Oct 22, 2024

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024 - The Bakersfield Californian

Oct 22, 2024
pulisher
Oct 20, 2024

Tectonic Therapeutic: Interesting CV Disease Drug Developer (NASDAQ:TECX) - Seeking Alpha

Oct 20, 2024
pulisher
Oct 14, 2024

Tectonic Therapeutic (NASDAQ:TECX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat

Oct 14, 2024
pulisher
Oct 10, 2024

Short Interest in Tectonic Therapeutic (NASDAQ:TECX) Increases By 258.0% - MarketBeat

Oct 10, 2024
pulisher
Oct 10, 2024

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial - Yahoo Finance

Oct 10, 2024
pulisher
Oct 09, 2024

Tectonic Therapeutic (NASDAQ:TECX) Shares Down 4.5%Here's Why - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

Vida Ventures Advisors LLC Takes $31.17 Million Position in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome - Yahoo Finance

Oct 08, 2024
pulisher
Oct 05, 2024

89,029 Shares in Tectonic Therapeutic (NASDAQ:TECX) Acquired by Renaissance Technologies LLC - MarketBeat

Oct 05, 2024
pulisher
Oct 04, 2024

Tectonic Therapeutic (NASDAQ:TECX) Hits New 52-Week HighHere's Why - MarketBeat

Oct 04, 2024
pulisher
Oct 02, 2024

Tectonic Therapeutic (NASDAQ:TECX) Trading 5.8% Higher - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 7% - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Navigating Uncertainty: Tectonic Therapeutic’s Clinical Data Volatility and Its Impact on Business Stability - TipRanks

Oct 01, 2024
pulisher
Sep 27, 2024

Insider Activity Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com Nigeria

Sep 27, 2024
pulisher
Sep 27, 2024

Tectonic Therapeutic director buys shares worth over $1.4 million By Investing.com - Investing.com South Africa

Sep 27, 2024
pulisher
Sep 26, 2024

Timothy A. Springer Acquires 50,000 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Tectonic Therapeutic director buys shares worth over $1.4 million - Investing.com India

Sep 26, 2024
pulisher
Sep 26, 2024

Tectonic Therapeutic (NASDAQ:TECX) Short Interest Update - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World

Sep 25, 2024

Tectonic Therapeutic Inc Azioni (TECX) Dati Finanziari

Non sono disponibili dati finanziari per Tectonic Therapeutic Inc (TECX). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):